Across 9 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Explore the full record of transactions filed by Flores Jessica. Director active across 2 companies, notably Sabra Health Care REIT, Inc.. In total, 14 filings have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €260k. History available since 5 January 2024. The latest transaction was disclosed on 25 March 2026 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
FLORES JESSICA is a declarant linked to Sabra Health Care REIT, Inc., where the listed role is Executive VP & CAO. The record shows 10 filings in total, and across the sampled period from 2024-01-09 to 2025-03-04, the transaction nature is Attribution, with sum_buy_eur at 0 and sum_sell_eur at 0.